ISPC — iSpecimen Inc.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1558569 ·
Last close
$1.21
Market Cap
$3.05M
52W High
$53.20
52W Low
$1.17
ADV30
1,319,374
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 151,940 | 68,650 | -1,362,986 | -1,362,811 | 7,393,201 | 4,414,364 | 5,656,821 |
| Mar 2026 | 156,009 | 71,599 | -2,538,403 | -2,275,221 | 6,609,658 | 2,818,989 | 5,795,620 |
| Dec 2025 | 51,761 | -547,078 | -2,687,882 | -5,001,245 | 9,531,410 | 6,880,835 | 6,443,179 |
| Sep 2025 | 106,592 | -98,001 | -2,830,222 | -2,780,648 | 8,997,557 | 2,782,758 | 5,924,846 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-6,506,609
Investing CF
$-1,700,454
Financing CF
$10,243,489
CapEx
$-1,773,060
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-330.95
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-84,625,370
Inventory
$0
Receivables
$132,848
ST Investments
$0
EBIT TTM
$-11,101,983
Pretax Income TTM
$-11,104,357
Interest Exp TTM
$2,374
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$466,302
EBITDA
$-9,284,936
Free Cash Flow
$-5,581,286
Enterprise Value
$-471,133
Total Cash
$4,414,364
Total Debt
$240,903
Shares Out
2,518,590
Trailing EPS
$-50.48
Book Value
$1.14
ROE
-968.5%
ROA
-87.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,928,998 | -8,977,919 | -10,487,532 | 9,531,410 | 6,443,179 | 3,088,231 | -4,240,608 |
| Dec 2024 | 9,291,115 | -12,728,045 | -12,497,805 | 9,350,230 | 6,039,222 | 3,311,008 | -8,263,713 |
| Dec 2023 | 9,928,184 | -11,169,349 | -11,099,488 | 15,819,137 | 6,078,060 | 9,741,077 | -5,807,550 |
| Dec 2022 | 10,402,303 | -10,186,082 | -10,245,922 | 24,617,653 | 4,308,483 | 20,309,170 | -5,817,720 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.79
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BUDZ | WEED, INC. | $3.68M | $0.02 | — |
| BIAF | bioAffinity Technologies, Inc. | $4.45M | $7.41 | — |
| VNRX | VOLITIONRX LTD | $4.78M | $0.25 | — |
| VRAX | Virax Biolabs Group Ltd | $1.84M | $2.31 | — |
| TRIB | TRINITY BIOTECH PLC | $5.46M | $6.72 | — |
News headlines (Yahoo Finance, 1h cache)
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks
2026-08-20 20:05 · Yahoo
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
2026-08-07 20:30 · Yahoo
E.F. Hutton & Co. Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
2026-08-07 19:45 · Yahoo
E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
2026-08-07 19:45 · Yahoo
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
2026-05-12 18:16 · Yahoo
iSpecimen Announces 1-for-40 Reverse Stock Split
2026-04-24 13:00 · Yahoo
iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time
2026-04-09 20:05 · Yahoo
iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
2026-08-06 12:30 · Yahoo
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
2026-05-09 01:04 · Yahoo
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research
2026-03-16 11:47 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.